OrbiMed Israel BioFund GP Limited Partnership

All filings by OrbiMed Israel BioFund GP Limited Partnership on record concern BiomX Inc. We count 11 filings; the first trade dates from 5 December 2019 and the latest from 15 May 2024.

In open-market terms, that means 9 purchases worth €260k on one side and 1 sale worth €8,522 on the other. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant. Since January 2024: no purchases and 1 sale on the market.

In size, the median ticket on the buying side is €27k. 8 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 20 May 2024, reports an open-market sale of €8,522 in BiomX Inc. The last insider purchase was made public on 17 March 2023, 1,317 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.